_version_ 1797786520588910592
author Şafak Mirioğlu
Arif Akyıldız
Ali Rıza Uçar
Ömer Uludağ
Yasemin Öztürk
Ahmet Burak Dirim
Erol Demir
Özgür Akın Oto
Işın Kılıçaslan
Yaşar Çalışkan
Halil Yazıcı
Aydın Türkmen
Mehmet Şükrü Sever
author_facet Şafak Mirioğlu
Arif Akyıldız
Ali Rıza Uçar
Ömer Uludağ
Yasemin Öztürk
Ahmet Burak Dirim
Erol Demir
Özgür Akın Oto
Işın Kılıçaslan
Yaşar Çalışkan
Halil Yazıcı
Aydın Türkmen
Mehmet Şükrü Sever
author_sort Şafak Mirioğlu
collection DOAJ
first_indexed 2024-03-13T01:10:05Z
format Article
id doaj.art-bd4380ceaab54168a9aa850821c49cea
institution Directory Open Access Journal
issn 2667-4440
language English
last_indexed 2024-03-13T01:10:05Z
publishDate 2023-07-01
publisher AVES
record_format Article
series Turkish Journal of Nephrology
spelling doaj.art-bd4380ceaab54168a9aa850821c49cea2023-07-06T04:53:35ZengAVESTurkish Journal of Nephrology2667-44402023-07-0132320921510.5152/turkjnephrol.2023.22140439Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?Şafak Mirioğlu 0 Arif Akyıldız1 Ali Rıza Uçar 2 Ömer Uludağ 3Yasemin Öztürk 4 Ahmet Burak Dirim 5Erol Demir 6 Özgür Akın Oto7 Işın Kılıçaslan 8 Yaşar Çalışkan9 Halil Yazıcı 10 Aydın Türkmen11Mehmet Şükrü Sever 12Division of Nephrology, Department of Internal Medicine, İstanbul University, İstanbul School of Medicine, İstanbul, Türkiye; Division of Nephrology, Department of Internal Medicine, Bezmialem Vakıf University, School of Medicine, İstanbul, TürkiyeDivision of Nephrology, Department of Internal Medicine, İstanbul University, İstanbul School of Medicine, İstanbul, TürkiyeDivision of Nephrology, Department of Internal Medicine, İstanbul University, İstanbul School of Medicine, İstanbul, TürkiyeDivision of Nephrology, Department of Internal Medicine, İstanbul University, İstanbul School of Medicine, İstanbul, TürkiyeDepartment of Pathology, İstanbul University, İstanbul School of Medicine, İstanbul, TürkiyeDivision of Nephrology, Department of Internal Medicine, İstanbul University, İstanbul School of Medicine, İstanbul, TürkiyeDivision of Nephrology, Department of Internal Medicine, İstanbul University, İstanbul School of Medicine, İstanbul, TürkiyeDivision of Nephrology, Department of Internal Medicine, İstanbul University, İstanbul School of Medicine, İstanbul, TürkiyeDepartment of Pathology, İstanbul University, İstanbul School of Medicine, İstanbul, TürkiyeDivision of Nephrology, Department of Internal Medicine, İstanbul University, İstanbul School of Medicine, İstanbul, Türkiye; Division of Nephrology, Department of Internal Medicine, Saint Louis University, School of Medicine, MO, USADivision of Nephrology, Department of Internal Medicine, İstanbul University, İstanbul School of Medicine, İstanbul, TürkiyeDivision of Nephrology, Department of Internal Medicine, İstanbul University, İstanbul School of Medicine, İstanbul, TürkiyeDivision of Nephrology, Department of Internal Medicine, İstanbul University, İstanbul School of Medicine, İstanbul, Türkiyehttps://turkjnephrol.org/en/low-versus-standard-dose-of-rituximab-in-adult-patients-with-relapsed-or-refractory-primary-membranous-nephropathy-does-it-make-any-difference-137130
spellingShingle Şafak Mirioğlu
Arif Akyıldız
Ali Rıza Uçar
Ömer Uludağ
Yasemin Öztürk
Ahmet Burak Dirim
Erol Demir
Özgür Akın Oto
Işın Kılıçaslan
Yaşar Çalışkan
Halil Yazıcı
Aydın Türkmen
Mehmet Şükrü Sever
Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?
Turkish Journal of Nephrology
title Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?
title_full Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?
title_fullStr Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?
title_full_unstemmed Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?
title_short Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?
title_sort low versus standard dose of rituximab in adult patients with relapsed or refractory primary membranous nephropathy does it make any difference
url https://turkjnephrol.org/en/low-versus-standard-dose-of-rituximab-in-adult-patients-with-relapsed-or-refractory-primary-membranous-nephropathy-does-it-make-any-difference-137130
work_keys_str_mv AT safakmirioglu lowversusstandarddoseofrituximabinadultpatientswithrelapsedorrefractoryprimarymembranousnephropathydoesitmakeanydifference
AT arifakyıldız lowversusstandarddoseofrituximabinadultpatientswithrelapsedorrefractoryprimarymembranousnephropathydoesitmakeanydifference
AT alirızaucar lowversusstandarddoseofrituximabinadultpatientswithrelapsedorrefractoryprimarymembranousnephropathydoesitmakeanydifference
AT omeruludag lowversusstandarddoseofrituximabinadultpatientswithrelapsedorrefractoryprimarymembranousnephropathydoesitmakeanydifference
AT yaseminozturk lowversusstandarddoseofrituximabinadultpatientswithrelapsedorrefractoryprimarymembranousnephropathydoesitmakeanydifference
AT ahmetburakdirim lowversusstandarddoseofrituximabinadultpatientswithrelapsedorrefractoryprimarymembranousnephropathydoesitmakeanydifference
AT eroldemir lowversusstandarddoseofrituximabinadultpatientswithrelapsedorrefractoryprimarymembranousnephropathydoesitmakeanydifference
AT ozgurakınoto lowversusstandarddoseofrituximabinadultpatientswithrelapsedorrefractoryprimarymembranousnephropathydoesitmakeanydifference
AT isınkılıcaslan lowversusstandarddoseofrituximabinadultpatientswithrelapsedorrefractoryprimarymembranousnephropathydoesitmakeanydifference
AT yasarcalıskan lowversusstandarddoseofrituximabinadultpatientswithrelapsedorrefractoryprimarymembranousnephropathydoesitmakeanydifference
AT halilyazıcı lowversusstandarddoseofrituximabinadultpatientswithrelapsedorrefractoryprimarymembranousnephropathydoesitmakeanydifference
AT aydınturkmen lowversusstandarddoseofrituximabinadultpatientswithrelapsedorrefractoryprimarymembranousnephropathydoesitmakeanydifference
AT mehmetsukrusever lowversusstandarddoseofrituximabinadultpatientswithrelapsedorrefractoryprimarymembranousnephropathydoesitmakeanydifference